Literature DB >> 24934647

Cellular signaling in the aging immune system.

Tamas Fulop1, Aurélie Le Page2, Carl Fortin2, Jacek M Witkowski3, Gilles Dupuis4, Anis Larbi5.   

Abstract

Causes for immunosenescence and inflamm-aging have to be established. Efficient function of the immune system requires homeostatic regulation from receptor recognition of antigenic challenge to cell responses and adaptation to its changing environment. It is reasonable to assume that one of the most important molecular causes of immunosenescence is alteration in the regulation of signaling pathways. Indeed, alterations in feed-forward and negative feedback (inhibitory) signaling have been highlighted in all cells involved in the immune response including short-lived (neutrophils) and long-lived (T lymphocytes) cells. These dysregulations tip the balance in favor of altered (less efficient) function of the immune system. In this review, we summarize our knowledge on signal transduction changes in the aging immune system and propose a unifying mechanism as one of the causes of immunosenescence. Modulation of these pathways with aging represents a major challenge to restore the immune response to functional levels.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24934647     DOI: 10.1016/j.coi.2014.05.007

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  55 in total

1.  The expression and functional evidence for voltage-dependent potassium channel Kv1.3 in lymphocytes during aging in spontaneously hypertensive rats.

Authors:  Ling-Peng Wang; Jian Luo; Hai-Feng Hu; Li Zhang; Ya-Li Li; Li-Man Ai; Yu-Ling Wang; Yi-Tong Ma; Hu-Yati Mu; Yue-Mei Hou
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  The P5 disulfide switch: taming the aging unfolded protein response.

Authors:  Akash Mathew
Journal:  Cell Stress Chaperones       Date:  2015-06-05       Impact factor: 3.667

Review 3.  The biology of aging and lymphoma: a complex interplay.

Authors:  Clémentine Sarkozy; Gilles Salles; Claire Falandry
Journal:  Curr Oncol Rep       Date:  2015-07       Impact factor: 5.075

4.  Innovative approach to older patients with malignant hemopathies.

Authors:  Dominique Bron; Pierre Soubeyran; Tamas Fulop
Journal:  Haematologica       Date:  2016-08       Impact factor: 9.941

Review 5.  Intracellular signalling pathways: targets to reverse immunosenescence.

Authors:  T Fulop; J M Witkowski; A Le Page; C Fortin; G Pawelec; A Larbi
Journal:  Clin Exp Immunol       Date:  2016-08-03       Impact factor: 4.330

Review 6.  Immunosenescence and hurdles in the clinical management of older HIV-patients.

Authors:  Marco Ripa; Stefania Chiappetta; Giuseppe Tambussi
Journal:  Virulence       Date:  2017-02-21       Impact factor: 5.882

Review 7.  Systemic sclerosis-associated fibrosis: an accelerated aging phenotype?

Authors:  Tracy R Luckhardt; Victor J Thannickal
Journal:  Curr Opin Rheumatol       Date:  2015-11       Impact factor: 5.006

Review 8.  Aging of the immune system: Focus on inflammation and vaccination.

Authors:  Marcello Pinti; Victor Appay; Judith Campisi; Daniela Frasca; Tamas Fülöp; Delphine Sauce; Anis Larbi; Birgit Weinberger; Andrea Cossarizza
Journal:  Eur J Immunol       Date:  2016-10       Impact factor: 5.532

Review 9.  An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides.

Authors:  Jiang Cheng; Zhi-Wei Zhou; Hui-Ping Sheng; Lan-Jie He; Xue-Wen Fan; Zhi-Xu He; Tao Sun; Xueji Zhang; Ruan Jin Zhao; Ling Gu; Chuanhai Cao; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-12-17       Impact factor: 4.162

10.  Immunomodulatory role of high-density lipoproteins: impact on immunosenescence.

Authors:  Anis Larbi; Carl Fortin; Gilles Dupuis; Hicham Berrougui; Abdelouahed Khalil; Tamas Fulop
Journal:  Age (Dordr)       Date:  2014-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.